Status:

RECRUITING

Effect of Atelocollagen Injection in Patients With Calcific Tendinitis

Lead Sponsor:

Hyungsuk Kim

Conditions:

Calcific Tendinitis of Shoulder

Atelocollagen

Eligibility:

All Genders

20-69 years

Phase:

PHASE4

Brief Summary

Assess the clinical outcomes using atelocollagen injection in patients with calcific tendinitis.

Detailed Description

Suitable participants based on the selection/exclusion criteria are randomly assigned to either the case group or the control group. Consent is given right before the procedure. Case group (Atelocoll...

Eligibility Criteria

Inclusion

  • Patients in whom calcification of 5mm or more is observed in plain radiographs.
  • In cases where concomitant medication is administered continuously during the clinical trial period, patients who have verified the exact prescribed medication taken within the last week and agreed to maintain the same amount throughout the study period.
  • Individuals who have agreed to participate in this study and have given written consent themselves.

Exclusion

  • Patients with a medical history of infectious arthritis, rheumatoid arthritis, tumors, or fractures.
  • Patients with hypersensitivity.
  • Patients with a history of anaphylactic reactions.
  • Patients with ongoing autoimmune diseases or a past medical history of such diseases, either in the patient or their family members.
  • Patients who are allergic to transplants. ⑥ Patients who are allergic to porcine (pig) proteins.
  • ⑦ Patients deemed unsuitable for this trial based on the judgment of the trial administrator, such as those with mental illnesses.
  • ⑧ Patients who have received intra-articular steroid or other injection treatments within one month prior to the procedure decision.
  • ⑨ Patients who are on concomitant medications that include oral steroids.

Key Trial Info

Start Date :

December 6 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2025

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT06040112

Start Date

December 6 2023

End Date

June 1 2025

Last Update

April 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Eunpyeong St. Mary's Hospital, The Catholic University of Korea

Seoul, South Korea, 03341